The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies
- PMID: 28838410
- DOI: 10.1016/j.gtc.2017.05.004
The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies
Abstract
Individuals with a genetic predisposition to Crohn's disease develop aberrant immune responses to environmental triggers. The gastrointestinal microbiota is increasingly recognized to play an important role in the development of Crohn's disease. Decrease in global gut microbial diversity and specific bacterial alterations have been implicated in Crohn's disease. Advances in sequencing techniques and bioinformatics and correlation with host genetics continue to improve insight into the structure and function of the microbial community and interactions with the host immune system. This article summarizes the existing literature on the role of the gut microbiome and its manipulation in the development and management of Crohn's disease.
Keywords: Crohn's disease; Fecal microbiota transplantation; Gut microbiota; Inflammatory bowel disease; Microbiome; Pathogenesis; Probiotics.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Dysbiotic gut microbiome: A key element of Crohn's disease.Comp Immunol Microbiol Infect Dis. 2015 Dec;43:36-49. doi: 10.1016/j.cimid.2015.10.005. Epub 2015 Oct 25. Comp Immunol Microbiol Infect Dis. 2015. PMID: 26616659 Review.
-
Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook.J Gastroenterol Hepatol. 2017 Nov;32(11):1804-1812. doi: 10.1111/jgh.13861. J Gastroenterol Hepatol. 2017. PMID: 28677158 Review.
-
Exploring gut microbiota as a novel therapeutic target in Crohn's disease: Insights and emerging strategies.World J Gastroenterol. 2025 Jan 14;31(2):100827. doi: 10.3748/wjg.v31.i2.100827. World J Gastroenterol. 2025. PMID: 39811502 Free PMC article. Review.
-
Role of gut microbiota and mesenteric adipose tissue in the pathology of Crohn's disease: Potential therapeutic targets.World J Gastroenterol. 2025 Apr 7;31(13):102291. doi: 10.3748/wjg.v31.i13.102291. World J Gastroenterol. 2025. PMID: 40248060 Free PMC article.
-
Gut microbiota in the pathogenesis of inflammatory bowel disease.Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29. Clin J Gastroenterol. 2018. PMID: 29285689 Review.
Cited by
-
Sparse species interactions reproduce abundance correlation patterns in microbial communities.Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2309575121. doi: 10.1073/pnas.2309575121. Epub 2024 Jan 24. Proc Natl Acad Sci U S A. 2024. PMID: 38266051 Free PMC article.
-
Factors Influencing Total Delay of Breast Cancer in Northeast of China.Front Oncol. 2022 Mar 2;12:841438. doi: 10.3389/fonc.2022.841438. eCollection 2022. Front Oncol. 2022. PMID: 35311134 Free PMC article.
-
Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.World J Gastroenterol. 2019 May 14;25(18):2204-2216. doi: 10.3748/wjg.v25.i18.2204. World J Gastroenterol. 2019. PMID: 31143071 Free PMC article.
-
Fecal microbiota live - jslm (Rebyota™/RBL) for management of recurrent Clostridioides difficile infection.Future Microbiol. 2024;19(14):1243-1251. doi: 10.1080/17460913.2024.2364583. Epub 2024 Jul 11. Future Microbiol. 2024. PMID: 38989699 Free PMC article. Review.
-
Bacterial distribution on the ocular surface of patients with primary Sjögren's syndrome.Sci Rep. 2022 Feb 2;12(1):1715. doi: 10.1038/s41598-022-05625-w. Sci Rep. 2022. PMID: 35110614 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical